{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:56:19Z","timestamp":1774302979974,"version":"3.50.1"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100011684","name":"Crohn\u2019s & Colitis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Despite recent developments in therapy for inflammatory bowel diseases (IBDs), there have been limited advances in diagnostic tools available to aid in disease management. A growing body of evidence suggests that there are important host-microbe interactions at the mucosal interface that modulate the inflammatory response in patients with IBD. Additionally, the importance of mucosal integrity and its disruption appears to be important in the pathophysiology and perpetuation of the disease. The ability to characterize this interface may provide valuable information for both disease monitoring and identification of new treatment targets. Endoscopy remains the primary tool for disease monitoring, and mucosal healing is the primary therapeutic target in IBD treatment. However, establishing mucosal healing requires repetitive endoscopic procedures, and endoscopy is limited by factors such as invasiveness, cost, and risk of adverse events. Moreover, the use of a bowel preparation for colonoscopies alters the mucus layer and thus perturbs evaluation of the host-microbe interaction. Stool sampling may also be inaccurate because it reflects the end state of metabolites and proteins, failing to take into account the degradation or alteration of substrates of interest by bacterial proteases and other enzymes during passage through the colon.<\/jats:p>\n               <jats:p>A novel sampling capsule, called the Recoverable Sampling System (RSS), is being developed as a complementary tool to colonoscopy. The RSS is intended to be a platform for noninvasive autonomous sampling, preservation, handling, and storage of analytes of interest found in the gastrointestinal fluids. A proprietary preservative contained within the chambers of the capsule has been developed to stabilize DNA and proteins for ex vivo microbiome and metabolomics analyses.<\/jats:p>\n               <jats:p>Surrogate markers such as SPP24 and GUCA2a have been identified to correlate with gut health, intestinal permeability, and inflammation and could be locally sampled by the RSS. The potential clinical utility of an RSS device is broad and would likely be able to guide therapy by allowing for more frequent disease monitoring, aiding in disease characterization, and facilitating in the identification of novel therapeutic targets.<\/jats:p>","DOI":"10.1093\/ibd\/izab179","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T03:52:31Z","timestamp":1637207551000},"page":"S17-S24","source":"Crossref","is-referenced-by-count":13,"title":["Current Trends in IBD\u2014Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System"],"prefix":"10.1093","volume":"27","author":[{"given":"Yunki Y","family":"Yau","sequence":"first","affiliation":[{"name":"School of Medical Sciences, Faculty of Medicine, The University of New South Wales , Sydney, NSW , Australia"},{"name":"Department of Gastroenterology, Concord Repatriation General Hospital , Sydney, NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie C","family":"Wasinger","sequence":"additional","affiliation":[{"name":"Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, The University of New South Wales , Sydney, NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P","family":"Hirten","sequence":"additional","affiliation":[{"name":"Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-6595","authenticated-orcid":false,"given":"Emil","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merodean","family":"Huntsman","sequence":"additional","affiliation":[{"name":"University of Utah, School of Medicine , Salt Lake City, UT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Stylli","sequence":"additional","affiliation":[{"name":"Georgetown University, School of Medicine , Washington D.C. , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Progenity, Inc , San Diego, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Yajnik","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals , Cambridge MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Smith","sequence":"additional","affiliation":[{"name":"Progenity, Inc , San Diego, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoying N","family":"Lee","sequence":"additional","affiliation":[{"name":"Progenity, Inc , San Diego, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharat","family":"Singh","sequence":"additional","affiliation":[{"name":"Progenity, Inc , San Diego, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Wahl","sequence":"additional","affiliation":[{"name":"Progenity, Inc , San Diego, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert W","family":"Leong","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, Faculty of Medicine, The University of New South Wales , Sydney, NSW , Australia"},{"name":"Department of Gastroenterology, Concord Repatriation General Hospital , Sydney, NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E","family":"Sands","sequence":"additional","affiliation":[{"name":"Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"2023102622525281800_CIT0001","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet."},{"key":"2023102622525281800_CIT0002","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet."},{"key":"2023102622525281800_CIT0003","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jcmgh.2016.06.004","article-title":"A disease-associated microbial and metabolomics state in relatives of pediatric inflammatory bowel disease patients","volume":"2","author":"Jacobs","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0004","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","article-title":"A microbial signature for Crohn\u2019s disease","volume":"66","author":"Pascal","year":"2017","journal-title":"Gut."},{"key":"2023102622525281800_CIT0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cgh.2017.06.016","article-title":"Natural history of adult ulcerative colitis in population-based cohorts: a systematic review","volume":"16","author":"Fumery","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0006","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterol."},{"key":"2023102622525281800_CIT0007","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/ibd\/izaa210","article-title":"Defining the path forward for biomarkers to address unmet needs in inflammatory bowel diseases","volume":"26","author":"Honig","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"2023102622525281800_CIT0008","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis."},{"key":"2023102622525281800_CIT0009","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cgh.2013.07.022","article-title":"Histologic remission: the ultimate therapeutic goal in ulcerative colitis?","volume":"12","author":"Peyrin-Biroulet","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5217\/ir.2018.16.1.55","article-title":"Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis","volume":"16","author":"Narang","year":"2018","journal-title":"Intest Res."},{"key":"2023102622525281800_CIT0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gut.2006.104182","article-title":"Inflammatory bowel disease: is it really just another break in the wall?","volume":"56","author":"Weber","year":"2007","journal-title":"Gut."},{"key":"2023102622525281800_CIT0012","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1749-6632.2009.04062.x","article-title":"Epithelial tight junctions in intestinal inflammation","volume":"1165","author":"Schulzke","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"2023102622525281800_CIT0013","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2012.152","article-title":"The gut microbiota in IBD","volume":"9","author":"Manichanh","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0014","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.rmr.2016.11.003","article-title":"[The human gut microbiota: interactions with the host and dysfunctions]","volume":"34","author":"Lepage","year":"2017","journal-title":"Rev Mal Respir."},{"key":"2023102622525281800_CIT0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cgh.2018.08.078","article-title":"The microbiome in patients with inflammatory diseases","volume":"17","author":"Somineni","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0016","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat Microbiol."},{"key":"2023102622525281800_CIT0017","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","article-title":"Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review","volume":"158","author":"Pittayanon","year":"2020","journal-title":"Gastroenterology."},{"key":"2023102622525281800_CIT0018","article-title":"Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers","volume":"92:1\u201315","author":"Duranti","year":"2016","journal-title":"FEMS Microbiol Ecol."},{"key":"2023102622525281800_CIT0019","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cgh.2019.08.063","article-title":"Features of fecal and colon microbiomes associate with responses to biologic therapies for inflammatory bowel diseases: a systematic review","volume":"18","author":"Estevinho","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe."},{"key":"2023102622525281800_CIT0021","article-title":"Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study","author":"Clooney","year":"2020","journal-title":"Gut."},{"key":"2023102622525281800_CIT0022","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cgh.2018.09.017","article-title":"Microbiome 101: studying, analyzing, and interpreting gut microbiome data for clinicians","volume":"17","author":"Allaband","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrmicro3552","article-title":"Gut biogeography of the bacterial microbiota","volume":"14","author":"Donaldson","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"2023102622525281800_CIT0024","article-title":"High-throughput stool metaproteomics: method and application to human specimens","volume":"5:1\u201315","author":"Gonzalez","year":"2020","journal-title":"mSystems."},{"key":"2023102622525281800_CIT0025","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3389\/fmicb.2019.01883","article-title":"A robust and universal metaproteomics workflow for research studies and routine diagnostics within 24 h using phenol extraction, FASP digest, and the MetaProteomeAnalyzer","volume":"10","author":"Heyer","year":"2019","journal-title":"Front Microbiol."},{"key":"2023102622525281800_CIT0026","article-title":"The Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study","volume":"11:1\u20138","author":"Williams","year":"2021","journal-title":"Br Med J Open."},{"key":"2023102622525281800_CIT0027","article-title":"Molecular pathophysiology of epithelial barrier dysfunction in inflammatory bowel diseases","volume":"6:1\u201317","author":"Lee","year":"2018","journal-title":"Proteomes."},{"key":"2023102622525281800_CIT0028","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"2023102622525281800_CIT0029","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mi.2010.77","article-title":"To be or not to be a pathogen: that is the mucosally relevant question","volume":"4","author":"Sansonetti","year":"2011","journal-title":"Mucosal Immunol."},{"key":"2023102622525281800_CIT0030","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.1000092107","article-title":"Epithelial crosstalk at the microbiota-mucosal interface","volume":"108 Suppl 1","author":"Wells","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2023102622525281800_CIT0031","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1038\/emm.2017.20","article-title":"Roles of intestinal epithelial cells in the maintenance of gut homeostasis","volume":"49","author":"Okumura","year":"2017","journal-title":"Exp Mol Med."},{"key":"2023102622525281800_CIT0032","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/17474124.2019.1671822","article-title":"Microbiota and mucosal defense in IBD: an update","volume":"13","author":"Stange","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0033","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/gut.33.3.331","article-title":"Natural course of Crohn\u2019s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms","volume":"33","author":"Olaison","year":"1992","journal-title":"Gut."},{"key":"2023102622525281800_CIT0034","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/0140-6736(93)90882-H","article-title":"Intestinal permeability and the prediction of relapse in Crohn\u2019s disease","volume":"341","author":"Wyatt","year":"1993","journal-title":"Lancet."},{"key":"2023102622525281800_CIT0035","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/gast.2000.20231","article-title":"Increased intestinal permeability precedes the onset of Crohn\u2019s disease in a subject with familial risk","volume":"119","author":"Irvine","year":"2000","journal-title":"Gastroenterology."},{"key":"2023102622525281800_CIT0036","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2017.05.056","article-title":"Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing","volume":"153","author":"Chang","year":"2017","journal-title":"Gastroenterology."},{"key":"2023102622525281800_CIT0037","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12967-020-02558-8","article-title":"High Smad7 in the early post-operative recurrence of Crohn\u2019s disease","volume":"18","author":"Zorzi","year":"2020","journal-title":"J Transl Med."},{"key":"2023102622525281800_CIT0038","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.gie.2015.08.045","article-title":"The learning curve, interobserver, and intraobserver agreement of endoscopic confocal laser endomicroscopy in the assessment of mucosal barrier defects","volume":"83","author":"Chang","year":"2016","journal-title":"Gastrointest Endosc."},{"key":"2023102622525281800_CIT0039","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1038\/s41598-020-69746-w","article-title":"Spp24 is associated with endocytic signaling, lipid metabolism, and discrimination of tissue integrity for \u2018leaky-gut\u2019 in inflammatory bowel disease","volume":"10","author":"Wasinger","year":"2020","journal-title":"Sci Rep."},{"key":"2023102622525281800_CIT0040","doi-asserted-by":"crossref","first-page":"e72645","DOI":"10.1371\/journal.pone.0072645","article-title":"Secreted phosphoprotein 24 kD (Spp24) and Spp14 affect TGF-\u03b2 induced bone formation differently","volume":"8","author":"Tian","year":"2013","journal-title":"Plos One."},{"key":"2023102622525281800_CIT0041","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcb.24376","article-title":"Secreted phosphoprotein-24\u2009kDa (Spp24) attenuates BMP-2-stimulated Smad 1\/5 phosphorylation and alkaline phosphatase induction and was purified in a protective complex with alpha2 -Macroglobulins From Serum","volume":"114","author":"Zhao","year":"2013","journal-title":"J Cell Biochem."},{"key":"2023102622525281800_CIT0042","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1074\/mcp.M115.055095","article-title":"Low mass blood peptides discriminative of inflammatory bowel disease (IBD) severity: a quantitative proteomic perspective","volume":"15","author":"Wasinger","year":"2016","journal-title":"Mol Cell Proteomics."},{"key":"2023102622525281800_CIT0043","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365521.2020.1748224","article-title":"Plasma levels of guanylins are reduced in patients with Crohn\u2019s disease","volume":"55","author":"von Volkmann","year":"2020","journal-title":"Scand J Gastroenterol."},{"key":"2023102622525281800_CIT0044","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1158\/1055-9965.EPI-14-0440","article-title":"The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer","volume":"23","author":"Wilson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2023102622525281800_CIT0045","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1053\/j.gastro.2020.12.076","article-title":"Inflamed ulcerative colitis regions associated with MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology."},{"key":"2023102622525281800_CIT0046","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell."},{"key":"2023102622525281800_CIT0047","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/ibd\/izz077","article-title":"Challenges in IBD research: novel technologies","volume":"25","author":"Dhyani","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2023102622525281800_CIT0048","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/ismej.2011.212","article-title":"The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates","volume":"6","author":"Zoetendal","year":"2012","journal-title":"Isme J."},{"key":"2023102622525281800_CIT0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/00365529009091905","article-title":"Gastrointestinal motility in patients with ulcerative colitis","volume":"172","author":"Rao","year":"1990","journal-title":"Scand J Gastroenterol Suppl."},{"key":"2023102622525281800_CIT0050","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otab045","article-title":"Development of a novel drug delivery system to facilitate organ specific delivery of liquid, peptide, and protein drugs directly to the colonic mucosa, resulting in improved efficacy and reduced systemic exposure, for the treatment of ulcerative colitis","author":"Huntsman","year":"2021","journal-title":"Crohn\u2019s Colitis 360."},{"key":"2023102622525281800_CIT0051","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1038\/s41598-018-23296-4","article-title":"Methodology challenges in studying human gut microbiota - effects of collection, storage, DNA extraction and next generation sequencing technologies","volume":"8","author":"Panek","year":"2018","journal-title":"Sci Rep."},{"key":"2023102622525281800_CIT0052","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2016.02.014","article-title":"Gastrointestinal stability of therapeutic anti-TNF \u03b1 IgG1 monoclonal antibodies","volume":"502","author":"Yadav","year":"2016","journal-title":"Int J Pharm."},{"key":"2023102622525281800_CIT0053","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"2023102622525281800_CIT0054","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cgh.2018.02.024","article-title":"Combining biologics in inflammatory bowel disease and other immune mediated inflammatory disorders","volume":"16","author":"Hirten","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0055","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cgh.2019.08.063","article-title":"Features of fecal and colon microbiomes associate with responses to biologic therapies for inflammatory bowel diseases: a systematic review","volume":"18","author":"Estevinho","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0056","doi-asserted-by":"crossref","first-page":"S479","DOI":"10.1093\/ecco-jcc\/jjz203.696","article-title":"P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018\/EB8018), in patients with Crohn\u2019s disease (CD)","volume":"14","author":"Reinisch","year":"2020","journal-title":"J Crohn\u2019s Colitis."},{"key":"2023102622525281800_CIT0057","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/14728222.2017.1363184","article-title":"The potential of FimH as a novel therapeutic target for the treatment of Crohn\u2019s disease","volume":"21","author":"Sivignon","year":"2017","journal-title":"Expert Opin Ther Targets."},{"key":"2023102622525281800_CIT0058","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41575-020-0331-7","article-title":"Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD","volume":"17","author":"Kudelka","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2023102622525281800_CIT0059","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2020.12.059","article-title":"Colonic epithelial-derived selenoprotein P is the source for antioxidant-mediated protection in colitis-associated cancer","volume":"160","author":"Short","year":"2021","journal-title":"Gastroenterology."},{"key":"2023102622525281800_CIT0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3748\/wjg.v27.i2.162","article-title":"Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis","volume":"27","author":"Motooka","year":"2021","journal-title":"World J Gastroenterol."},{"key":"2023102622525281800_CIT0061","doi-asserted-by":"crossref","first-page":"543022","DOI":"10.3389\/fimmu.2020.543022","article-title":"Endoplasmic reticulum stress and intestinal inflammation: a perilous union","volume":"11","author":"Eugene","year":"2020","journal-title":"Front Immunol."},{"key":"2023102622525281800_CIT0062","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2013.01.023","article-title":"The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice","volume":"144","author":"Cao","year":"2013","journal-title":"Gastroenterology."},{"key":"2023102622525281800_CIT0063","doi-asserted-by":"crossref","first-page":"G259","DOI":"10.1152\/ajpgi.00354.2017","article-title":"Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms","volume":"315","author":"Golden","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"2023102622525281800_CIT0064","doi-asserted-by":"crossref","first-page":"e0180673","DOI":"10.1371\/journal.pone.0180673","article-title":"Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages","volume":"12","author":"Ko","year":"2017","journal-title":"Plos One."},{"key":"2023102622525281800_CIT0065","doi-asserted-by":"crossref","first-page":"e14456","DOI":"10.14814\/phy2.14456","article-title":"The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis","volume":"8","author":"Lajczak-McGinley","year":"2020","journal-title":"Physiol Rep."},{"key":"2023102622525281800_CIT0066","doi-asserted-by":"crossref","first-page":"e20192195","DOI":"10.1084\/jem.20192195","article-title":"The role of IL-22 in intestinal health and disease","volume":"217","author":"Keir","year":"2020","journal-title":"J Exp Med."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/Supplement_2\/S17\/52624548\/izab179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/Supplement_2\/S17\/52624548\/izab179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T22:53:23Z","timestamp":1698360803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/27\/Supplement_2\/S17\/6428473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":66,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2021,11,15]]},"published-print":{"date-parts":[[2021,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izab179","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,2]]},"published":{"date-parts":[[2021,11,15]]}}}